只用一本书提高英语听力能力!重温经典名著双语阅读小编推荐:跟着纪录片学英语不背单词和语法,轻松学英语
返回列表 回复 发帖

[report整理] SENEWS-2010-03-29

提高英语听力能力 找对方法很重要!

[report整理] SENEWS-2010-03-29

本帖最后由 csufor 于 2010-3-30 12:33 编辑

SENEWS-20100329 Report


Development   Report


user posted image




【电信用户1】在线播放和下载
user posted image user posted image

【电信用户2】在线播放和下载
user posted image user posted image


【网通/教育网】在线播放和下载 (推荐教育网用户用网通这个服务器下载)


user posted image user posted image

【迅雷高速】下载
user posted image user posted image

版主提示:
一、若是自己的听写稿, 请发帖时标注'Homework'.
二、若是改稿, 请发帖时标注'on 某某人'并在修改处标红.
三、为了达到最快的下载速度,推荐使用迅雷高速下载本站音频/视频材料.

 

 

This is the VOA Special English Development Report.

 

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at a reduced price.  Pfizer and GlaxoSmithKline signed the historic Advance Market Commitment agreement last week.  The Global Alliance for Vaccines and Immunizations, or GAVI, helped negotiate the deal.  The group says the low cost vaccines could save as many as seven million lives by the year twenty thirty.

 

The World Health Organization says pneumonia kills almost two million children each year.  This is more than AIDS, malaria and measles combined.  It is the leading cause of death among young children. And more than ninety percent of those deaths happen in the developing world.

 

These are all reasons why GAVI chose the pneumococcal vaccine for its first Advance Market Commitment project. The private-public partnerships are designed to increase the availability of low cost vaccines in poor areas.

 

Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Melinda Gates Foundation.  They provided one and a half billion dollars to launch the pneumococcal vaccine project. Jeffrey Rowland is with the GAVI alliance.  He says the money helps to persuade drug makers to take part in the project.

 

JEFFREY ROWLAND: "The biggest challenge of getting life saving vaccines to poor countries is that there's no market.  People can't afford them.  That's why we don't really have a malaria vaccine yet, because no one in rich countries really suffers from malaria.  What we did for the pneumococcal vaccine was we said we will pay one point five billion dollars if you develop the right vaccines, and the right volumes that we need and at the right price. And it was a gamble."

 

That gamble paid off. GlaxoSmithKline and Pfizer have agreed to provide thirty million doses of the vaccine each year for ten years.  The first twenty percent of the vaccines will sell for seven dollars a dose.  The remaining eighty percent will cost three dollars and fifty cents per dose.  That is ninety per cent less than current prices in the United States.

 

Mister Rowland says the agreement is a huge achievement for the developing world.

 

JEFFREY ROWLAND: "Vaccination, which we tend to take for granted in countries like the United States or in Western Europe, in fact a lot of us don't even know which diseases we've been vaccinated against.  That's not the case in poor countries.  Vaccination is a life or death question for poor people and if you can vaccinate a child to prevent a disease from happening it is a lot more cost effective than it is to treat that disease afterwards."

 

And that's the VOA Special English Development Report, written by June Simms. I'm Steve Ember.

 

每日Report生词链接:

http://forum.putclub.com/viewthread.php?tid=183726&extra=page%3D1&page=12


 

普特在线文本比较普特在线听音查字普特在线拼写检查普特文本转音频

支持普特英语听力就多多发帖吧!您们的参与是对斑竹工作最大的肯定与支持!如果您觉得还不错,推荐给周围的朋友吧~
HOMEWORK

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease N*. Two leading drug companies have agreed to supply vaccines againt normal c* disease to the world's poorest countries at a reduced price. F* and G* Smith C* signed the historic advance market commitment agreement last week. The global alliance for vaccines and i* or * help negotiate the deal. The group the low cost viccines could save as many as seven million lives by the year 2030. The World Health Organization says N* kills almost two million children each year. This is more then AIDS, m* and m* combined. It is the leading cause of death among young children. And more than 90% of those death happen in the developing world.

These are all reasons why G* choose the N* C* vaccine for its first advance market commitment project. The private public partnerships are designed to increase the availability of low cost vaccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia, and Norway, joined with the bill and m* foundation. They provided one and a half biilion dollars to launch the N* vaccine project. J* R* diswith the g* alliance. He says the money helps to persuade drug makers to take part in the project. "the biggest chance is getting * vaccines to poor countries that is no market. People can afford them. * we don't have M* vaccines. Because no one in rich countries really suffer from M*. Where we did for the N* vaccine was we said, we will pay 125 billion dollars, if you develop the right vaccines and right volumn that we need, at the right price. And it was a gamble."

That gamble paid off. G* and F* have agreed to provide 30 million dose of the vaccine each year for ten years. The first twenty percent of the vaccines was sell for seven dollars a dose. The remaining eighty percent will cost three dollars and fifty cents per dose. That is ninety percent less than current prices in the United States. Mr Rollen says the agreement is a huge achievement for the developing world. "Dec* which we tend to take for granted, in countries like United States, or *. A lot of those don't even know which diseases we've been destinate against. That's not a case in poor countries. D* is life or death question for poor people. And if you can vaccinate a child, to prevent this disease from happening, that is a lot more cost effective than it is to treat the disease afterwards."

And that's the VOA Special English Development Report, written by June Simms. I’m Steve Ember.
1

评分次数

  • csufor


SE REPORT
SE 15:30 NEWS
CNN
SSS OR VOA
立即获取| 免费注册领取外教体验课一节

[Homework]SENEWS-2010-03-29

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at a reduced price.

F and B signed the historic advance market commitment agreement last week. The global allies for vaccines and immunizations or G helped negotiated the deal.

The group says the low cost vaccines could save as many as seven million lives by the year twenty thirty.

The World Healthcare Organization says pneumonia kills almost two million children each year. This is more than AIDS, malaria and measles combined. It is the leading cause of deaths among young children. And more than ninety percent of those deaths happen in the developing world. These are all reasons why G choose the pneumococcal vaccine for its first advance market commitment project.

The private public partnerships are designed to increase the avalibality of low cost vaccines in poor areas. Last year the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with a bill and M Gates Fundation. They provided one and a half billion dollars to launch the pneumococcal vaccine project.

J is with the G allies. He says the money helps to persuade drug makers to take part in the project.  The biggest change is that you getting vaccine support countries there is no market. People can afford them we don't have malaria vaccine, because no one in rich countries really suffer from malaria. While we did for the pneumococcal vaccine was we said. We will pay one point five billion dollars if you develop the right vaccines in the right ... that we need and the right price. And it was the gamble.

That gamble payed off. G and F have agreed to provide thirty million dosis of vaccines each year for ten years. The first twenty percent of the vaccines will sell for seven dollars a dosis. The remaining eighty percent will cost three dollars and fifty cents per dosis. That is ninety percent less than current prices in the United States.

Mister W says the agreement is a huge acheivement for the developing world.  Vaccinations which we tend to take for guranted in countries like the United States or in Western Europe that a lot of ... to know which disease we've been vaccinated against. That not a case for poor countries. Vaccination is a life of death question for poor people. You can vaccinate a child to prevent the disease when happening. It is a lot more cost infectives than it is to treat that disease after words.

And that's the VOA Special English Development Report, written by June Simms. I'm Steve Ember.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

实现无障碍英语沟通

[Homework]SENEWS-2010-03-29

This is the  VOA Special English Development Report.Millions of babies and children could soon be protected against the deadly disease Nomonia.Two leading drug companies have a grade to supply that things against no more cucle disease to the world's poorest countries at a reduced price.F and B signed a historical advanced market commitment agreement last week.The global alliance for backthings and immunizations for help associated the deal.The group says the low cost back could save as many as 7 million lives by the year 2030.The world health organization says N kills almost 200 million children each year.This is more than A,M,and M combined. It is the leading cause of death among young children.And more than 90 percent of those deaths happen in the developing world.These are all reasons why Cucle chose the no more cucle backthing for its first advance commitment project.The private public partnerships are designing to  increase the availability of low cost backthings in poor areas. Last year,the governments of Italy,the United Kingdom,Canada,Russia and Norway joined with the bills and Melinda Gates Foundation.They provide one and a half billion dollars to launch no more cucle backthing project.J G is with alliance.He says the money helps persuade the drug makers to take part in the project.The biggest challenge for getting is that there is no market ,people can't afford them, We don't have a Nomonia yet because no one in rich countries really suffers the Nomonia.What we did for the nomo cucle backthing is that we will pay 1.5 billion dollars if you develop the right backthings and right we need and the right price.And it was a gamble.That gamble paid off.Black had a grade to provide 30 million dose of the backthing each year for 10 years.The first 20 percent of the backthings will sell for 7 dollars a dose.The remaining 80 percent will cost 3 dollars and 50 cents per dose.That is 19 percent less than current prices in the United States. Mr. W says the agreement is a huge achievement for the developing world. that we can't take for granted in countries like United States or in western Europe e.A lot of even did not which disease we've back against.That's not a case in poor countries,ba is a life or death for poor people.And if you can a child to prevent the disease from having,it is lot of more cost effective than it is should treat the disease afterwards.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

口译专员推荐—>口译训练软件IPTAM口译通
Homework:
This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against deadly disease newmonia. Two leading drug companies have agreed to supply vaccines against newmocaco disease to the world's poorest countries at a reduced price. Fiser and G signed the historic advance market commitment to agreement last week. The global allies for vaccines and immunizations or * help negotiate the deal. The group says the low cost vaccines could save as many as seven million lives by the year twenty thirty.

The World Health Organization says newmonia kills almost two million children each year. This is more than aids, m and measles combined. It is the leading cause of death among young children. And more than ninety percent of those death happen in developing world. These are all reasons why G chose the newmocaco vaccine for its first advance market commitment project.

The private public partnerships are design to increase the availability of low cost vaccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the bill and MG *. They provided one and half billion dollars to launch the newmocaco vaccine project.

JR is with the * aligns. He says the money helps to persuade drug makers to take part in the project.

"The biggest challenge of getting * vaccines to poor countries is there is no market. People can't afford them. **** We don't have M vaccines because no one in rich country through suffer from newmonia. While we did for the newmocaco vaccine was we said we will pay one point five billion dollars. If you developed the right vaccines and the * we need and the right price. And it was a gamble."

That gamble paid off. G and Fiser have agreed to provide thirty million doses of the vaccine each year for ten years. The first twenty percent of the vaccines will sell for seven dollars a dose. The remaining eighty percent will cost three dollars and fifty cents per dose. That is ninety percent less than current prices in the United States. Mr.W says the agreement is a huge achievement for developing world.

"Vaccination which we take for granted in countries like United States *** a lot of them even don't know which disease we been * against. That's not the case in poor countries. Vaccinations is a life or death question for poor people. And if you can vaccine a child to prevent disease from happening. It's a lot of more costing than it is to treat that disease after words."

And that's the VOA Special English Development Report, written by June Simms.  I'm Steve Ember.
1

评分次数

  • csufor

[Homework]SENEWS-2010-03-29

This is the VOA Special English Development Report.

Millions of babys and children could soon be protected against the deadly desieas Nomonia.  Two leading drug companies have agreed to suply back things against nomoal caco desieas to the world poorest countries at reduced price. Fither and Black so Smith Cline signed the historical advanced market commitment agreement last week.

The gobal aliance for back things and imminisation or gabes help negosiate the deed. The group says the low cost back things could save as many as seven million lives by the year 2030. The world health organization says Nomonia kills almost two million children each year. This is more than AIDS, Maleria and Miso combine. It is the leading cause of death among young children. And more than ninty percent of those death happen in the developing world. These are all reasons why gabe chose the numoral caco back thing for its first advanced market commitement projects.

The private public partnerships are designed to increase the avilablity of low cost back things in poor areas. Last year, the governments of Italiy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Maliinda Gites Foundation. They provided one and half billion dollars to launch the numoal caco back thing project.

Jefory Rollen is with the garbe alliance. He says the money helps to persived durg makers to take part in the project.  The biggest challange geting ** and ** support countires is there is no market, people cannot afford them. We don't have maliria back thing there. Because on one in that coutry really sufer from maliria. While we did for the numoal caco vacine was we said we will pay 125 billion dollars if you develop the right vacines in right ** we need at the right price. And it was a gamble.

That gamble pay doufle. Black and Smith Cline and Fither have agreed to provide 30 million doses of the vacine each year for ten years. The first 20 percent of the vacine will sale for seven dollars a dose. The remain eighty percent will cost three dollars and fifty cents for a dose. That is ninty percent less than current price in the United States. Mr. Wolane says the agreement is a huge cheapment for the developing world.  Back thing nations we take for grantee in countires like United States or in Westen Europe. A lot of those still donnot know which desides to fight against . That's a not case in poor countires. Vacines is a life or death question for poor people. And if you can can vacined a child to provent desides from happening it is a lot more  low cost than it is to treat the desides after words.

And that's the VOA Special English Development Report, written by June Sams. I'm Steve Ember.




This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

[Homework]SENEWS-2010-03-29

mollions of babies and children could soon be protected from deadly desease.the group saids  as many as 70 millions by the year 2040  .almost 2 millions children each year.than 90 percent of that happen developing work.
last year the goverment of ,the ukingdom ,canada,lusor,nuoway,they provideit one million dollars.
He said the money helps way to take part in the project .We will pay 1.5 million dollars.

This post was generated by put listening repetition system,  Check the original dictation thread!
实现无障碍英语沟通

[Homework]SENEWS-2010-03-29

This is the VOA Speicial English Devolopment report. Millions of babies and children could soon be protected against the dead disease Nomonia. Two leading drug companies have agreeed to supply vaccines against nomokacal* disease to the world's poorest countries at reduced price.  Feather and Black so smith cline* sign the historic advance market commitment agreement last week.

The global alians for viccines and inmunisations or ** help negotiate the deal. The group says, the low cost vaccines could save as many as 7 million lives by the year 2030. The World Health Organisation says, nomonia kills almost 2 million children each year. This is more than As, Mas, and Mis combined. It is the leading cause of dead among young children. And more than 90% of those death happen in the developing world. These are all reasons why Gavi chose the Nomocaco vaccine for its first advance market commitment project.

The private pubulic partenerships are designed to increase the availability of low cost vaccines in poor areas. Last year, the gorverments of Italy, The United Kindom, Canada, Russa, Norway joined with a bill and Malindagates Foundation. They provided one and a half billion dollars to launch the nomocacal vaccine project. Jeffry Roland is with again* the alians. He says, the money helps to persuade drug makers to take part in the project.

The biggest challenge to getting * vaccines in poor countries is there is no market.People can't affort. And for what we don't have a molaria vaccine yet, because no one in rich countries really suffers from molaria. Well we did for the nomocacal vaccine as we said, we will pay 1.5 billion dollars, if you develope the right vaccines, and right * there we need and the right price. And it was a gambel. That gambel paid off.

Glacso Smith Cline and Feather has agreed to provide 30 million doses of the vaccine each year for 10 years. The first 20% of the vaccines will sell for 7 dollars a dose. The remaining 80% will cost 3 dollars and 50 cents per dose. That is 90% less than current prices in the United States. Mr Wallen says, the agreement is a huge treatment for the developing world.

Descanation* which we can't take for granted, in countries like united states or in **.We always don't even know which diseases we've been descanate against. Em, that is not the case in poor countries. Descanation is a life or death question for poor people. And if you can vaccine a child to prevent the disease from happening, it is a lot work cast effective than it is to treat the disease afterwards.

And that's the VOA Special English development reprot. Written by Junc Sims. I'm Steve Ember.

今天听得很差... 好多话都是胡说八道呢...






This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

普特听力大课堂
Hw
This is the VOA Special English development report.
Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world’s poorest countries at a reduced price.
Pfizer and Glaxo Smith Kline signed the historic advance market commitment agreement last week.
The global alliances for vaccines and immunizations or GAVI help negotiate the deal. The group says the low cost vaccines could save as many as 7 million lives by the year 2030.
The World Health Organization says pneumonia kills almost 2 million children each year. This is more than AIDS, malaria and measles combined. It is the leading cause of death among young children.
More than 90% of those deaths happen in the developing world. These are all reasons why GAVI chose the pneumococcal vaccine for its first advanced market commitment project. The private public partnerships are designed to increase the availability of low cost vaccines in poor areas. Last year the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Melinda Gates Foundation. They provided 1.5 billion dollars to launch the pneumococcal vaccine project.
Jeffery Rowland is with the GAVI alliance, he says the money helps to persuade drug-makers to take part in the projects.
The biggest challenge of getting life saving vaccine to poor countries is that no market, people can’t afford them. That’s why we don’t really have; we don’t have a malaria vaccine yet. Because no one in rich countries really suffers from malaria, what we did for the pneumococcal vaccine was we said we will pay 1.5 billion dollars. If you develop the right vaccines and the right volumes that we need and at the right price, and it was a gamble.  
That gamble paid off. Glaxo Smith Kline and Pfizer have agreed to provide 30 million doses of the vaccine each year for 10 years.
The first 20% of the vaccines will sell for 7 dollars a dose, the remaining 80% will cost 3.5 dollars per dose. That is 90% less than current prices in the United States.
Mr. Rowland says the agreement is the huge achievement for the developing worlds.
Vaccination which we tend to take for granted in  countries like the United States or in West Europe, in fact a lot of us don’t even know which diseases we’ve been vaccinated against. That’s not the cast in poor countries. Vaccination is the life or death questions for poor people. And if you can vaccinate the child to prevent the disease from happening to a lot more coughed effective than it is to treat that disease afterwards.
1

评分次数

  • csufor

要跳多少次才能飞起来?
好栏目推荐之美国口语俚语
hw
This is the VOA special English development report.

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed supply vaccines against pneumococcal disease to the world’s poorest countries at a reduced price.

  Phaizer and Glacso Smith Client signed the historic advance market commitment agreement last week. The Global Alliance for Vaccines and Immunizations, or GAVI, helped negotiate the deal. The group says the low cost vaccines could save as many as 7 million lives by the year 2030. The World Health Organization says pneumonia kills almost two million children each year. This is more than AIDs, malaria and missals combined. It is the leading cause of death among young children. And more than 90% of those deaths happen in the developing world. These are all reasons why GAVI chose the pneumococcal vaccine for its first advance market commitment project.

  The private public partnerships are designed to increase the availability of low cost vaccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Melinda Gates foundation. They provided one and a half billion dollars to launch the pneumococcal vaccine project.

  Jeffery Rollin is with the GAVI alliance. He said the money helps to persuade the drug makers to take part in the project.

  The biggest challenge of getting xxxx and vaccines in the poor countries is that there is no market. People cannot afford them. We don’t have a malaria vaccine yet, because no one in developed countries suffered from malaria. What we did for the pneumococcal vaccine was that we said we will pay 1.5 billion dollars if you developed the right vaccines in the right volume we need and in the right price. And it was a gamble.

  That gamble paid off. Glacso Smith Client and Phaizer have agreed to provide 30 million doses of vaccine each year for ten years. The first 20% vaccines will sell for seven dollars a dose. The remaining 80% will cost 3 dollars and 50 cents per dose. That is 90% less than current price in the United States.

  Mr. Wallen says the agreement is a huge achievement for the developing world.

  Vaccination which we take for granted in countries like United States or in Western Europe. A lot of don’t even know which diseases we have been vaccine against. That’s not the case in poor countries. Vaccination is a live or death question for poor people. And if you can vaccinate a child to prevent disease from happening, it is a lot more cost effective than it is to treat that disease afterwards.

  And that’s the VOA special English development report, written by June Simms. I’m Steve Ember.
1

评分次数

  • csufor

[Homework]SENEWS-2010-03-29

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against p* disease to the world's poorest countries at reduced price.

F.and B.. signed the historic advance market commitment agreement last week. The global allies for vaccines and * or * helped * the deal. The group says the low cost vaccines could save as many as seven million lives by the year 2030.

The World Healthcare Organization says pneumonia kills almost two million children each year. This is more than AIDS, malaria and m* combined. This is the leading cause of deaths among young children. And more than ninety percent of those deaths happen in the developing world.* reasons why Gabby choose the p* vaccine for its first advance market commitment project.

The private public partnerships are designed to increase the avalibality of low cost vaccines in poor areas. Last year the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with a bill and M gates Fundation. They provided one and a half billion dollars to launch the p* vaccine project.

J is with the Gubby allies. He says the money helps to persuade drug makers to take part in the project. The biggest change to getting vaccine support countries is there is no market. People can afford them we don't have malaria vaccine, because no one in rich countries really suffer from malaria. ...we said. We will pay one point five billion dollars if you develop the right vaccines and the right ... that we need at the right price. And it was the gamble.

That gamble paid off. G and F have agreed to provide thirty million dosises of vaccines each year for ten years. The first twenty percent of the vaccines will sell for seven dollars a dosis. The remaining eighty percent will cost three dollars and fifty cents per dosis. That is ninety percent less than current prices in the United States.

Mr. says the agreement is a huge acheivement for the developing world.* which we attend to guranted in countries like the United States or in Western Europe that a lot of those even know which disease we've been against. That not a case for poor countries.* is a life of death question for poor people. And if you can v a child to prevent the disease when happening. It is a lot more cost infectives than it is to treat that disease after words.

And that's the VOA Special English Development Report, written by June Simms. I'm Steve Ember.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

Homework

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease Pneumonia. Two leading drug companies have agreed to supply vaccines against - disease to the world's poorest countries at a reduced price. F- and G-  signed the historic advance market commitment the agreement last week.
The global alliance for vaccines and immunizations or g- helped negotiate the deal. The group says the low cost of vaccine could save as many as seven million lives by the year 2030.


The world health organization says pneumonia kills almost two million children each year. This is more than AIDS, malaria and measles combined. It is the leading cause of death among young children. And more than ninety percent of those deaths happen in the developing world. These are all reasons why g- chose the - vaccine for its first advanced market commitment project. The private public partnerships are designed to increase the availability of low cost vaccines in poor areas.

Last year the governments of Italy, The United Kingdom, Canada, Russia and Norway joined with the bill and M- gates foundation. They provided one and a half billion dollars to launch the - vaccine project.

Jeffrey Rowland is the with the g- alliance. He says the money helps to persuade drug makers to take part in the project. "The biggest challenge of getting - vaccines to poor countries is that there's no market. People can not afford them. That's why we don't really have a malaria vaccine yet, because no one in rich country really suffered from malaria. What we did for the - vaccine was we said we will pay one point five billion dollars if you develop the right vaccines, and the right - that we need and the right price. And it was a gamble."

That gamble paid off. G- and F- have agreed to provide thirty million dozes of the vaccines each year for ten years. The first twenty percent of the vaccines will sell for seven dollars a doze. The remaining eighty percent will cost three dollars and fifty cents per doze. That is ninety percent less than current prices in the United State.

Mr Rowland says the agreement is a huge achievement for the developing world. "Vaccination which we tend to take for granted in countries like the United States or in Western Europe, that a lot of us don't even know which disease we've been - against. That's not the case in poor countries. Vaccination is a life or death question for poor people. And few can vaccinate child to prevent a disease from happening. It is a lot more cost effective than it is to treat that disease after worlds."

And that's the VOA Special English Development Report, written by June Simms. I'm Steve Ember.
1

评分次数

  • csufor

每天半小时 轻松提高英语口语
On erdongfang

This is the VOA Special English Development Report.

Millions of babies and children could soon be protected against the deadly disease
Pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at a reduced price. F- and G- Smith Cline signed the historic advance market commitment agreement last week. The Global Alliance for Vaccines and Immunizations or GAVI help negotiate the deal.


The group ^says the low cost vaccines could save as many as seven million lives by the year 2030. The World Health Organization says Pneumonia kills almost two million children each year. This is more than AIDS, malaria and measles combined. It is the leading cause of death among young children. And more than 90% of those deaths happen in the developing world.

These are all reasons why Gavin ch
ose the pneumococcal vaccine for its first advance market commitment project. The private public partnerships are designed to increase the availability of low cost vaccines in poor areas. Last year, the governments of Italy, the United Kingdom, Canada, Russia, and Norway, joined with the bill and Melinda Gates Foundation. They provided one and a half billion dollars to launch the pneumococcal vaccine project.


J- R- diswith the GAVI alliance. He says the money helps to persuade drug makers to take part in the project.

"the biggest chance is getting * vaccines to poor countries that is no market. People can afford them. I swear we don’t really, we don't have malaria vaccines yet. Because no one in rich countries really suffer from malaria. Where we did for the pneumococcal vaccine was we said, we will pay 125 billion dollars, if you develop the right vaccines and right volume that we need, at the right price. And it was a gamble."

That gamble paid off. G- and F- have agreed to provide 30 million dose of the vaccine each year for ten years. The first twenty percent of the vaccines was sell for seven dollars a dose. The remaining eighty percent will cost three dollars and fifty cents per dose. That is ninety percent less than current prices in the United States. Mr
. Rollin says the agreement is a huge achievement for the developing world.


"Vaccination which we tend to take for granted, in countries like United States, or in *. A lot of those don't even know which diseases we've been d- against. That's not a case in poor countries. Vaccination is life or death question for poor people. And if you can vaccinate a child, to prevent this disease from happening, it is a lot more cost effective than it is to treat that disease afterwards."

And that's the VOA Special English Development Report, written by June Simms. I’m Steve Ember.



专有名词很多,查了很久额~~~今天的不容易额~~~
1

评分次数

  • csufor

[Homework]SENEWS-2010-03-29

This is the VOA special English, development report
Millions of babies and children could soon be protected aganist the deadly disease - Nomonia. Two leading drug companies have agreed to supply vaccine aganist normal caracol disease to the world poorest countries at reduced prise. Fiser and Glacsor Simith Cl signed the historic advanced market committent agreement last week. The global alliance for vaccines and immunization or gavi help negoiate the deel. The group says the low cost vaccines could save as many as 7 million lives by the year 2030.
The world health organization says Nomonia kills almost 2 millions children each year. This is more than AIDS, Molaria and Misers combined. It is the leading cause of dearth among young children and more than 90 percent of those dearth happen in the developing world.
There are all reasons why gavi chose the normal caracol vaccine for its first advanced market commitment project. The private public parternship are designed to increase the avaliability of low cost vaccines in poor areas. Last year the government of Italy, The United Kingon, Canada, Russia and Noway join with the Bill and Merllinda gates fundation. They provide one and a half billions dollars to launch the normal caracol vaccine project.
Jefferi Roland is with the gavi alliance , he says the money help to persuade drug maker to take part in the project.
A biggest challenge getting li* and vaccine support country and their business market people can afford them, I afraid we really don't have Malaria vaccine because no one in ruch country really suffer from Malaria. What we did for the normal caracol vaccine as we said we will pay 1.5 billions dollars if you develop the right vaccines and right volume that we need and the right price. And it will be a gamble.
That gamble paid off Glacsor Simith Cl and Fiser at a agree to provide 30 millions doses of the vaccines each year for ten years. The first 20% of the vaccines wil sell for 7 dollars one dose, the remainning 80% will cost 3 dollars and 50 cents per dose. That is 90% less than current price in the United States.
Mr. Wollen says the agreement is a huge achievement for the developing world.
Destination which we take for granted in country like United States or in western Europe that a lots of us don't even know which diseases we've been destilly aganist. That is not the case to poor country, destination as the life or dearth are question for poor people. and if you can vaccinate a child to prevent the disease from happening at a lot more cost effective than it is true treat that disease afterward.
And that's the VOA special English development report, written by June Sins,I am Steve Weber.


This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

口译专员推荐—>口译训练软件IPTAM口译通

[Homework]SENEWS-2010-03-29

This is the VOA Special English Develpment Report.

Millions of babies and children could soon be protected against the deadly disease pneumonia. Two leading drug companies have agreed to supply vaccines against pneumococcal disease to the world's poorest countries at reduced price.

** and ** signed the historic advance market commitment agreement last week. The Global Alliance for Vaccines and Immunizations or GAVI helped negotiate the deal. The group says the low-cost vaccines could save as many as seven million lives by the year 2030.

The World Health Organization says pneumonia kills almost two million children each year. This is more than AIDS, malara and measles combined. It is the leading cause of death among young children. And more than ninety percent of those happen in the developing world.

These are reasons why GAVI choose the pneumococcal  vaccine for its first advance market commitment project. The private public partnerships are designed to increase the availability of low-cost vaccins in poor areas.

Last year, the governments of Italy, the United Kingdom, Canada, Russia and Norway joined with the Bill and Melinda Gates Foundation. They provided one and a half billion dollars to launch the pneumococcal vaccin project. J. R. is with the GAVI alliance, he says the money helps to persuade drug makers to take part in the project.

The biggest challenge of getting life ** vaccines to poor countries is that there is no market, people cannot afford them. That's why we don't have malaria vaccine yet because no one in rich countries really suffers from malaria. What we did for pneumococcal  vaccine was we said we'll pay one twenty five million dollars if you develop the right vaccines and the right volumes that we need and at the right price. And it was a gamble.

That gamble paid off. ** and ** have agreed to provide thirty million doses of vaccine each year for ten years. The first twenty percent of the vaccines will sell for seven dollars a dose, the remaining eighty percent will cost three dollars and fifty cents per dose. That is ninety percent less than current prices in the United States.Mr.R says the agreement is a huge achievement for the developing world.

Vaccination which we tend to  take for granted in countries like the United States or in western Europe. In fact, a lot of us don't even know which disease we've been vaccinated against. That's not a case in poor countries, vaccination is a life or death question for poor people. And if you can vaccinate a child to prevent disease from happening, it is a lot more effective than it to treat that disease afterwards.

And that's the VOA Special English Development Report, written by June Simms. I'm Steve Ember.

This post was generated by put listening repetition system,  Check the original dictation thread!
1

评分次数

  • csufor

返回列表